How Doctolib's Hegemony is Squeezing French Clinics

Doctolib's monopoly traps French clinics in costly dependency. Data silos and high fees block networks from analyzing the patient journey.

"The companies winning in 2026 aren't growing fastest — they're growing most efficiently. The Rule of 40 has been replaced by the Rule of 50 among best-in-class operators."

Work with Stratos

Ready to drive better returns?

Let's talk